SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Biocon reports 13% rise in Q3 consolidated net profit

22 Jan 2016 Evaluate

Biocon has reported results for third quarter ended December 31, 2015.

The company has registered 19.55% rise in its net profit at Rs 68.5 crore for the quarter under review, as compared to Rs 57.3 crore for the same quarter in the previous year. Total income of the company has increased 3.25% at Rs 565.3 crore for Q3FY16 as compared Rs 547.5 crore for the corresponding quarter previous year.

On the consolidated basis, the company’s net profit rose 13.31% to Rs 103 crore for the Q3 FY16 as compared to Rs 90.9 crore in Q3 FY15. Moreover, the total income surged 9.90% to Rs 856.1 crore in the quarter under review as compared to Rs 779 crore in the corresponding quarter previous year.

Biocon Share Price

349.65 -8.15 (-2.28%)
24-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1619.95
Dr. Reddys Lab 1315.85
Cipla 1294.75
Zydus Lifesciences 927.15
Lupin 2296.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×